[On motor end-plate diseases with special reference to myasthenia gravis].
D000109:Acetylcholine / Q000378:metabolism*; D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000324:Adrenocorticotropic Hormone / Q000009:adverse effects; D000818:Animals; D000937:Antigen-Antibody Reactions; D001327:Autoimmune Diseases / Q000503:physiopathology; D006801:Humans; D009157:Myasthenia Gravis / Q000503:physiopathology*; D051381:Rats; D013148:Spironolactone / Q000627:therapeutic use; D013945:Thymoma / Q000276:immunology
D000305:Adrenal Cortex Hormones; D013148:Spironolactone; D000324:Adrenocorticotropic Hormone; D000109:Acetylcholine
Uber die motorischen Endlplattenerkrankungen unter besonderer Berücksichtigung der Myasthenia Gravis.